Key result
Concomitant hemiarch replacement during valve-sparing root replacement showed similar 10-year freedom from the primary composite outcome compared to no hemiarch replacement.
Why the study?
The indication and optimal timing for performing a hemiarch procedure in patients undergoing valve-sparing root replacement (VSRR) remained to be determined.
Does concomitant hemiarch replacement improve outcomes in adult patients undergoing elective valve-sparing root replacement?
Cohort (n=986)
Yes
Does concomitant hemiarch replacement improve outcomes in adult patients undergoing elective valve-sparing root replacement?
Concomitant hemiarch replacement during elective valve-sparing root replacement does not increase perioperative risk but also does not protect against medium-term aortic reinterventions.
Answers are grounded in this paper and cite their sources.
No support for routine hemiarch replacement in elective valve-sparing root replacement; leaves open optimal arch strategy in selected patients.
OBJECTIVE: The aim of this study was to determine the indication and optimal timing for performing a hemiarch procedure in patients undergoing valve-sparing root replacement (VSRR). METHODS: We conducted a retrospective study on 986 patients undergoing VSRR at three tertiary care centres. Inclusion criteria were all patients undergoing elective VSRR. Exclusion criteria were age <18 years, Stanford type A dissection, dissection in the arch, total aortic arch replacement or previous aortic arch replacement. We performed propensity score matching in a 1:1 ratio. The primary end-point is a composite outcome that includes mortality, aortic arch reintervention, new aortic dissection during follow-up and cerebrovascular incidents within the first 30 days. RESULTS: A total of 401 patients (41%) had a hemiarch replacement, while 585 (59%) did not. Root phenotype was present in 565 (57%). The mean follow-up time was 4.7 years (SD ± 4.6). In the matched population, there was no significant difference in the 10-year freedom from the composite outcome between the non-hemiarch and hemiarch groups (87.3% vs 85.0%, P > 0.999). Similarly, no difference was found for aortic reinterventions (P = 0.13) or survival (P = 0.5). This was also true for patients with heritable thoracic aortic disease. However, in patients with a bicuspid aortic valve, the intervention rate was significantly higher in the hemiarch group (10.8% vs 0%, P = 0.016). There was no significant difference in the 30-day incidence of cerebrovascular accidents between the groups (5% vs 2.7% in the hemiarch group, P = 0.117). Only the distal ascending diameter showed a tendency with better outcome over 45 mm for the hemiarch procedure; otherwise, we found no reliable cut-off values based on ascending length, diameter-to-height index or ascending length-to-height index. CONCLUSIONS: Our findings conclusively demonstrate that concomitant hemiarch replacement does not increase the perioperative risk in young patients undergoing VSRR. However, concomitant replacement does not seem to protect from aortic reinterventions during medium-term follow-up.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2025) conducted a cohort in Elective valve-sparing root replacement (VSRR) (n=986). Hemiarch replacement vs. No hemiarch replacement was evaluated on Composite of mortality, aortic arch reintervention, new aortic dissection during follow-up and cerebrovascular incidents within the first 30 days (p=> 0.999). Concomitant hemiarch replacement during valve-sparing root replacement showed similar 10-year freedom from the primary composite outcome compared to no hemiarch replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: